Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”

Yingzhe Zhang
Hepatology Research · Wiley · 2026-11-03 · DOI: 10.1111/hepr.70227

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles